Miles Capital’s Hologic HOLX Stock Holding History

Miles Capital’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-4,836	Closed	-$219K	–	201
2017 Q2	$219K	Sell	4,836 -3	-0.1%	-$132	0.12%	173
2017 Q1	$206K	Buy	+4,839	New	+$197K	0.11%	186

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Miles Capital's HOLX Position: Q3 2017 in Review

Miles Capital sold out of Hologic (HOLX) in Q3 2017, closing a stake of 4,836 shares — an estimated $219K sold.

Miles Capital first reported a position in HOLX in Q1 2017 and held it in 2 quarters. The position peaked at $219K in Q2 2017. 457 funds tracked by Wall St. Rank hold HOLX as of Q3 2017.

Miles Capital reported no remaining Hologic position as of Q3 2017 after selling out during the quarter.
Miles Capital sold 4,836 Hologic shares in Q3 2017, an estimated $219K.
Miles Capital first reported a position in Hologic in Q1 2017 and held it in 2 quarters.
Miles Capital's Hologic position peaked at $219K in Q2 2017.
457 funds tracked by Wall St. Rank held Hologic as of Q3 2017.

Based on Miles Capital's 13F filing for Q3 2017, filed 13 Nov 2017.